Skip to content
ScienceBlog.com
  • Featured Blogs
    • EU Horizon Blog
    • ESA Tracker
    • Experimental Frontiers
    • Josh Mitteldorf’s Aging Matters
    • Dr. Lu Zhang’s Gondwanaland
    • NeuroEdge
    • NIAAA
    • SciChi
    • The Poetry of Science
    • Wild Science
  • Topics
    • Brain & Behavior
    • Earth, Energy & Environment
    • Health
    • Life & Non-humans
    • Physics & Mathematics
    • Social Sciences
    • Space
    • Technology
  • Our Substack
  • Follow Us!
    • Bluesky
    • Threads
    • FaceBook
    • Google News
    • Twitter/X
  • Contribute/Contact

Metastatic Kidney Cancer

“We at City of Hope are the first to demonstrate a live bacterial product’s ability to improve clinical outcomes for patients with kidney cancer treated with immunotherapy. CBM588 could be exciting in cancer treatment because of its potential to enhance the efficacy of immune checkpoint inhibitor-based treatment, improve patient outcomes and modulate the gut microbiota in beneficial ways,” said Pal, a City of Hope medical oncologist and corresponding author of the Nature Medicine study.

Changing the gut microbiome improves health outcomes for people new metastatic kidney cancer

Substack subscription form sign up

Comments

  • Not Buying Yer Bullshit on More Than a Third of Americans Have Lost Relationships Over Politics
  • Marco Messina on More Than a Third of Americans Have Lost Relationships Over Politics
  • Anon on Why Fructose Behaves Less Like a Calorie and More Like a Hormone
  • Mark Mellinger on Living Plastic Can Self-Destruct on Command
  • Marie Feret on The Silent Frequency That Makes Old Buildings Feel Haunted
© 2026 ScienceBlog.com | Follow our RSS / XML feed